Updates & News from TII
Eric Buckland Inducted Into Medical And Biological Engineering Elite
June 5, 2020
The American Institute for Medical and Biological Engineering (AIMBE) announced the induction of Eric Buckland, Ph.D., to its College of Fellows.
The in-person induction ceremony was replaced with an online video ceremony. “Despite not being able to attend in person, family and friends were able to join in the video ceremony. I am honored to be included in the College of Fellows with such fantastic company,” Buckland said.
Dr. Buckland was nominated, reviewed, and elected by peers and members of the College of Fellows for “developing and commercializing Optical Coherence Tomography technologies that changed the way that clinicians and scientists image the eye.”
Translational Imaging Innovations FEATURED IN NORTH CAROLINA BIOTECHNOLOGY CENTER publication “NC medical software startup targets eye disorders, plans to locate in RTP”
MAY 12, 2020
Eric Buckland discussed TII’s origins and suite of software tools to help scientists and doctors get medical innovations into the eye clinic faster, with less frustration and at a lower cost.
“It is critical to leverage the untapped medical information hidden within these images to advance diagnosis and accelerate the development of new therapies to treat blinding eye disease,” Buckland said. “This program is the beginning of our mission to unleash the power of the eye and transform medicine.”
TII receives the Global Health and Pharma 2020 Biotechnology Award for BEST IMAGING SCIENCE WORKFLOW INTEGRATION SPECIALISTS
April 15, 2020
With our recent SBIR Direct to Phase II award and this honor from GHP, our products will continue to reach a large audience and provide our customers with new software tools to enhance vision research today and in the future.
TII Receives Direct-to-Phase II Award for Development of Photoreceptor Analysis Software
February 17, 2020
This Direct-to-Phase II Small Business Innovation Research (SBIR) award is a collaboration between Translational Imaging Innovations and the Advanced Ocular Imaging Program. Eric Buckland, Ph.D., CEO of TII, and Joseph Carroll, Ph.D., Professor of Ophthalmology & Visual Sciences and Director of AOIP, are co-Principal Investigators on the project.
TII will develop and apply Mosaic Analytics to automatically analyze the retinal photoreceptor mosaic from Adaptive Optics images of 1800 subjects afflicted by degenerative eye disease. TII is commercializing MOSAIC as the first commercial software package for quantitative analysis of non-invasive images of the human photoreceptor mosaic.